LIBRETTO-431: Confirming the Superiority of Selpercatinib to Chemotherapy and the Lack of Efficacy of Immune Checkpoint Inhibitors in Advanced RET Fusion-Positive (RET+) NSCLC, Another Unique Never-Smoker Predominant Molecular Subtype of NSCLC
Alexandria TM Lee,1 Sai-Hong Ignatius Ou2 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, 92868, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, 92868, USACorrespondence: Sai-Hong Ignatius Ou, Department of Medicine, Division of Hematology-Oncology...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Dove Medical Press
2024-05-01
|
| Seria: | Lung Cancer: Targets and Therapy |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.dovepress.com/libretto-431-confirming-the-superiority-of-selpercatinib-to-chemothera-peer-reviewed-fulltext-article-LCTT |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|